VR for Symptom Control and Wellbeing

Oncology Clinical Trial

Official title:

The Use of Virtual Reality for Symptom Control and Wellbeing in Palliative Care and Oncology Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04821466
• Other study ID #: 2021.RCHT.07
• Status: Completed
• Phase: N/A
• Start date: June 14, 2021
• Est. completion date: September 20, 2022

Study information

• Verified date: November 2023
• Source: Royal Cornwall Hospitals Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate the effect that a Virtual Reality experience can have on patient symptoms and wellbeing for palliative care and oncology inpatients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: September 20, 2022
• Est. primary completion date: September 20, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria

• > 18 years of age
• Inpatient at RCHT know to the palliative care team
• Able to consent
• Able to speak and understand the English language
• Able to use the virtual reality system
• Able to complete ESAS-r Questionnaire Exclusion criteria
• <18 years of age
• Patient unable to consent
• Patient unable to speak English
• Unable to use the virtual reality system (e.g. visually impaired)
• Known Epilepsy or seizures or suspected predisposition to seizures (e.g. Brain metastasis)

Related Conditions & MeSH terms

• End Stage Cancer
• Hematologic Malignancy
• Hematologic Neoplasms
• Neoplasms
• Oncology
• Palliative Care

Intervention

Device:
• Virtual Reality Headset to provide a Virtual Reality Experience
Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.

Locations

Country	Name	City	State
United Kingdom	Royal Cornwall Hospital	Truro	Cornwall

Sponsors (1)

Lead Sponsor	Collaborator
Royal Cornwall Hospitals Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Qualitative patient experience of VR interventions	Patients to answer: Were there any negative side effects of the VR session?	Time 60 minutes
Other	Repeat VR experiences	ESAS-r QoL Scores (0 to 10) will be collected each time a patient uses the experience to consider the effect repeat exposure has on wellbeing and symptoms. 0 = No symptoms to 10 = Worst Symptom	12 Months
Primary	ESAS-r Quality of Life Scores	Change in ESAS-r QoL score between start and finish of Virtual Reality experience. 0 = No symptoms to 10 = Worst Symptom	Time 0 & Time 60 minutes
Secondary	Quantitative clinician experience of VR intervention	Clinician score of patient experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)	Time 60 minutes
Secondary	Quantitative clinician experience of VR intervention	Patient score of experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)	Time 60 minutes